Victorian scientists are leading a world-first program that could transform understanding and treatment of a rare genetic ...

FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Dravet ...

Based on Stoke Therapeutics’ preliminary estimates, which scaled annual incidence to prevalence using country-specific live birth rates over the past 85 years and adjusted for Dravet-specific ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for ...

While the intention when imposing tariffs for imported goods may be to foster economic growth by protecting local industries, ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...

A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is ...

Children with more than one developmental condition – such as ADHD, autism or others – are at risk of depression or anxiety too. And health systems need to adapt.

Long-term data on the treatment of children and adults living with Lennox-Gastaut syndrome (LGS) with fenfluramine1 demonstrated sustained reduction in frequency of seizures associated with a fall and ...

The Founder of the Year Award is an element of the HPSU Founders Forum, which supports businesses to succeed internationally ...